PATENT CLAIM ANALYSIS

Application Number: 16061674
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "009440"]

Abstract:
The present invention relates to novel, radiolabeled mGluR2/3 ligands, selective versus other mGlu receptors which are useful for imaging and quantifying the metabotropic glutamate receptor mGlu2 and 3 in tissues, using positron-emission tomography (PET). The invention is also directed to compositions comprising such compounds, to processes for preparing such compounds and compositions, to the use of such compounds and compositions for imaging a tissue, cells or a mammal, in vitro or in vivo and to precursors of said compounds.

Claim (Index 2):
The compound for use according to  claim 1 , having the Formula or a pharmaceutically acceptable salt or a solvate thereof.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 94.0
- Lexical Diversity: 1.57895
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13505157', '15385490', '13062064', '15544850', '13453579']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7245617080343963
- 35 USC 102 Novelty (BERT): 0.4877731363540303
- Combined Prediction Score: 0.7008828508663598
- Mean Citation Score: 217.438352
- Max Citation Score: 225.56691
- Similarity Product: 177.36974253966633

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test